Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity...

Area of Science:

• Child and Adolescent Psychiatry
• Behavioral Psychology
• Pharmacological Treatments

Background:

• Attention deficit hyperactivity disorder (ADHD) presents significant challenges for families.
• Treatment decisions involve balancing efficacy, side effects, and social acceptability.
• Parental perception significantly influences treatment adherence and outcomes.

Purpose of the Study:

• To evaluate the social acceptability of methylphenidate, behavior modification, and a combined approach for ADHD.
• To compare acceptability ratings between families with ADHD children and control families.
• To assess changes in treatment acceptability after families gained experience with interventions.

Main Methods:

• A case vignette of an 8-year-old boy with ADHD was presented to 50 mothers of children with ADHD and 50 control mothers.
• Subjects rated the acceptability of three treatments: methylphenidate, behavior modification, and combined therapy.
• Mothers of children with ADHD were reassessed after 3.5 months of intervention experience.

Main Results:

• Behavior modification was rated as the most acceptable treatment by both ADHD and control families.
• Methylphenidate was rated as the least acceptable, with the combined condition falling in between.
• At follow-up, acceptability of methylphenidate and the combined treatment significantly improved.
• Increased methylphenidate acceptability correlated with enhanced parental knowledge of ADHD, not with symptom reduction.

Conclusions:

• Behavior modification is highly socially acceptable for managing ADHD.
• Parental knowledge and experience can positively influence the perceived acceptability of pharmacological and combined ADHD treatments.
• Treatment acceptability is a complex factor influenced by education and experience, independent of immediate behavioral outcomes.